DANIEL MUSHER to Drug Resistance, Microbial
This is a "connection" page, showing publications DANIEL MUSHER has written about Drug Resistance, Microbial.
Connection Strength
0.169
-
Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med. 2002 Feb 21; 346(8):630-1.
Score: 0.048
-
Polysaccharide vaccines: determinants of clinical efficacy. Hosp Pract (1995). 1997 Sep 15; 32(9):37-8, 41-4, 52-3 passim.
Score: 0.036
-
Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J Infect Dis. 1997 Mar; 175(3):590-7.
Score: 0.034
-
The gram-positive cocci: III. Resistance to antibiotics. Hosp Pract (Off Ed). 1988 May 15; 23(5):105-7, 111-2, 117-8 passim.
Score: 0.019
-
Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. Ann Intern Med. 1983 Oct; 99(4):444-50.
Score: 0.014
-
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999 Jan; 18(1):1-9.
Score: 0.010
-
Promotion of transposon Tn916 excision via exposure to streptomycin. J Infect Dis. 1993 Nov; 168(5):1334-5.
Score: 0.007
-
Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis. 1976 Jan; 133(1):14-21.
Score: 0.002